Table 4.
Category | Disease or function | Genes | p-value |
---|---|---|---|
Connective tissue development and function | Quantity of adipose tissue | ARID5B, CYB5R4 | 3.58E-4 |
RETN, TLR5 | |||
Connective tissue development and function | Differentiation of adipocytes | ARID5B, EGLN1 | 8.82E-4 |
NIPBL, RETN | |||
Cardiovascular disease | Angiectasis of blood vessel | EGLN1 | 9.87E-4 |
Cardiovascular system development and function | Area of capillary vessel | EGLN1 | 9.87E-4 |
Hematological system development and function | Cell division of | AIMP1 | 9.87E-4 |
peripheral blood lymphocytes | |||
Cardiovascular disease, endocrine system disorders, | Susceptibility to insulin | RETN | 9.87E-4 |
Metabolic disease | resistance-related hypertension | ||
Cardiac necrosis, cell death and survival | Cell death of heart tissue | EGLN1 | 1.97E-3 |
Cellular movement | Migration of connective tissue cells | AIMP1, ARID5B | 2.14E-3 |
RETN | |||
Carbohydrate metabolism, cellular function | Homeostasis of D-glucose | CYB5R4, RETN | 2.46E- 3 |
and maintenance | TLR5 | ||
Nucleic acid metabolism | Conversion of NAD+ | NNT | 2.96E- 3 |
Cardiovascular system development and function | Tethering of endothelial cell lines | FUT3 | 2.96E-3 |
Cellular compromise, inflammatory response | Degranulation of beta islet cells | CYB5R4 | 3.94E-3 |
Cardiovascular system development and function | Density of blood vessel tissue | AIMP1 | 3.94E-3 |
Endocrine system disorders, hematological disease | Onset of hyperglycemia | CYB5R4 | 3.94E-3 |
Metabolic disease | |||
Carbohydrate metabolism | Tolerance of D-glucose | CYB5R4 | 4.93E- 3 |
Cardiovascular system development and function | Angiogenesis of heart | EGLN1 | 5.91E-3 |
Cardiovascular system development and function | Density of blood vessel | AIMP1, EGLN1 | 5.96E-3 |
Immune cell trafficking, inflammatory response | Adhesion of neutrophils | ADGRE2 (EMR2) | 7.52E-3 |
Hematological system development and function | TLR5 | ||
Endocrine system development and function | Insulin sensitivity of liver | RETN | 7.87E-3 |
Hepatic system development and function | |||
Nucleic acid metabolism | Metabolism of NADPH | CYB5R4 | 7.87E-3 |
Connective tissue development and function | Quantity of visceral fat | RETN | 8.85E- 3 |
Carbohydrate metabolism | Binding of chondroitin sulfate | ADGRE2 (EMR2) | 9.83E-3 |
51 additional enriched diseases and biological functions (statistically less significant) with p-values ranging between 1.0E-2 and 5.0E-2 are listed in Additional file 1: Table S7